PPL three-lens brief
Evidence-based stock research on PPL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Negative free cash flow last quarterly (-$1.62B).
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $41.33 — 15% above current (15 analysts).
- Negative free cash flow last quarterly (-$1.62B).
- Earnings scheduled 2026-07-30.
PPL closed at $35.82 (+0.45%) as of 2026-07-10. Market cap: $26.95B. P/E (trailing) 22.0. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $41.33 — 15% above current (15 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; negative free cash flow last quarterly (-$1.62B).. Last quarter: Revenue $2.77B, net income $452.00M, free cash flow -$1.62B. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on PPL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PPLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PPL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PPL brief"></iframe>